1

                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    FORM 10-Q

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended March 25, 2001


                         Commission file number: 0-21154


                                   CREE, INC.
             (Exact name of registrant as specified in its charter)


            NORTH CAROLINA                                        56-1572719
    (State or other jurisdiction of                          (I.R.S. Employer
     incorporation or organization)                          Identification No.)


         4600 SILICON DRIVE
       DURHAM, NORTH CAROLINA                                        27703
(Address of principal executive offices)                          (Zip Code)


                                 (919) 313-5300
              (Registrant's telephone number, including area code)



Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. [X] Yes  [ ] No

The number of shares outstanding of the registrant's common stock, par value
$0.00125 per share, as of May 1, 2001 was 72,691,054.

   2

                                   CREE, INC.
                                    FORM 10-Q

                      For the Quarter Ended March 25, 2001


                                      INDEX



                                                                                              Page No.
                                                                                              --------


                                                                                           
PART I.    FINANCIAL INFORMATION

Item 1.    Financial Statements

           Consolidated Balance Sheets at March 25, 2001 (unaudited) and
           June 25, 2000                                                                         3

           Consolidated Statements of Operations for the three and nine months ended
           March 25, 2001 and March 26, 2000 (unaudited)                                         4

           Consolidated Statements of Cash Flow for the nine months ended
           March 25, 2001 and March 26, 2000 (unaudited)                                         5

           Notes to Consolidated Financial Statements (unaudited)                                6

Item 2.    Management's Discussion and Analysis of Financial Condition
           and Results of Operations                                                            14

Item 3.    Quantitative and Qualitative Disclosures About Market Risk                           20


PART II.   OTHER INFORMATION

Item 1.    Legal Proceedings                                                                    21

Item 2.    Changes in Securities

Item 6.    Exhibits and Reports on Form 8-K                                                     22

SIGNATURES                                                                                      23



   3

PART I - FINANCIAL INFORMATION
ITEM 1 - FINANCIAL STATEMENTS


                           CONSOLIDATED BALANCE SHEETS
                      (In thousands, except per share data)




                                                                                        March 25,         June 25,
                                                                                           2001             2000
                                                                                       -----------        ---------
                                                                                       (Unaudited)
                                                                                                    
ASSETS
Current assets:
       Cash and cash equivalents                                                        $ 117,102         $ 103,843
       Short-term investments, held to maturity                                            77,984           142,461
       Marketable securities, available for sale                                            9,644            15,842
       Accounts receivable, net                                                            31,540            12,406
       Interest receivable                                                                  2,261             3,893
       Inventories                                                                         15,853             9,320
       Deferred income taxes                                                                  139                --
       Prepaid expenses and other current assets                                            2,104             1,254
                                                                                        ---------         ---------
              Total current assets                                                        256,627           289,019

       Property and equipment, net                                                        215,853           137,118
       Long-term investments held to maturity                                               7,971            41,965
       Deferred income taxes                                                               10,624            10,624
       Patent and license rights, net                                                       2,882             2,324
       Intangible assets                                                                   85,736                --
       Other assets                                                                        31,822             5,152
                                                                                        ---------         ---------
              Total assets                                                              $ 611,515         $ 486,202
                                                                                        =========         =========

LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
       Accounts payable, trade                                                          $  15,765         $  14,204
       Accrued salaries and wages                                                           2,178             3,133
       Deferred income taxes                                                               15,785               455
       Other accrued expenses                                                               7,677             5,270
                                                                                        ---------         ---------
              Total current liabilities                                                    41,405            23,062
Long term liabilities:
       Long term liability                                                                    437                --
                                                                                        ---------         ---------
              Total long term liabilities                                                     437                --

Shareholders' equity:
       Preferred stock, par value $0.01; 3,000 shares authorized at March
         25, 2001 and June 25, 2000; none issued and outstanding                               --                --
       Common stock, par value $0.00125; 200,000 and 120,000 shares
         authorized at March 25, 2001 and June 25, 2000, respectively; shares
         issued and outstanding 72,686 and 70,696 at March 25, 2001 and
         June 25, 2000, respectively                                                           90                88
       Additional paid-in-capital                                                         508,466           415,716
       Deferred compensation expense                                                       (1,348)           (1,755)
       Retained earnings                                                                   69,490            48,156
       Accumulated other comprehensive (loss) income, net of tax                           (7,025)              935
                                                                                        ---------         ---------
              Total shareholders' equity                                                  569,673           463,140
                                                                                        ---------         ---------
              Total liabilities and shareholders' equity                                $ 611,515         $ 486,202
                                                                                        =========         =========



               The accompanying notes are an integral part of the
                       consolidated financial statements.


   4

                                   CREE, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                      (In thousands, except per share data)
                                   (Unaudited)



                                                        ---------------------------        ---------------------------
                                                            Three Months Ended                  Nine Months Ended
                                                        ---------------------------        ---------------------------

                                                        March 25,         March 26,        March 25,         March 26,
                                                          2001              2000             2001              2000
                                                        ---------         ---------        ---------         ---------
                                                                                                 
Revenue:
    Product revenue, net                                $  48,042         $  26,177        $ 119,940         $  66,561
    Contract revenue, net                                   5,323             3,351           12,561             8,641
                                                        ---------         ---------        ---------         ---------
         Total revenue                                     53,365            29,528          132,501            75,202

Cost of revenue:
    Product revenue                                        23,819            10,971           54,471            30,542
    Contract revenue                                        3,849             2,758            9,693             6,658
                                                        ---------         ---------        ---------         ---------
         Total cost of revenue                             27,668            13,729           64,164            37,200
                                                        ---------         ---------        ---------         ---------

Gross profit                                               25,697            15,799           68,337            38,002

Operating expenses:
    Research and development                                3,627             2,246            8,023             5,088
    Sales, general and administrative                       5,105             2,969           12,072             7,792
    Intangible asset amortization                           2,280                --            2,280                --
    In-process research and development                    17,400                --           17,400                --
         costs, one-time charge
    Other expense                                             158             1,169              220             1,261
                                                        ---------         ---------        ---------         ---------

         (Loss) income from operations                     (2,873)            9,415           28,342            23,861

Other non operating income                                    162               495               63               495
Interest income, net                                        3,824             3,768           12,929             4,894
                                                        ---------         ---------        ---------         ---------

         Income before income taxes                         1,113            13,678           41,334            29,250

Income tax expense                                          6,295             4,716           20,000            10,087
                                                        ---------         ---------        ---------         ---------
         Net (loss) income                              $  (5,182)        $   8,962        $  21,334         $  19,163
                                                        =========         =========        =========         =========

Other comprehensive (loss) income, net
of tax:
         Unrealized holding (loss) gain on
           available for sales securities                  (1,010)            7,039           (7,960)            6,602
                                                        ---------         ---------        ---------         ---------
Comprehensive (loss) income                             $  (6,192)        $  16,001        $  13,374         $  25,765
                                                        =========         =========        =========         =========
(Loss) earnings per share:
         Basic                                          $   (0.07)        $    0.13        $    0.30         $    0.30
                                                        =========         =========        =========         =========
         Diluted                                        $   (0.07)        $    0.12        $    0.28         $    0.28
                                                        =========         =========        =========         =========

Shares used in per share calculation:
         Basic                                             73,920            68,031           72,075            64,424
                                                        =========         =========        =========         =========
         Diluted                                           73,920            73,122           75,818            68,844
                                                        =========         =========        =========         =========



               The accompanying notes are an integral part of the
                       consolidated financial statements.

   5

                                   CREE, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOW
                                 (In thousands)



                                                                                       Nine Months Ended
                                                                                 ----------------------------
                                                                                  March 25,         March 26,
                                                                                    2001              2000
                                                                                 -----------        ---------
                                                                                         (Unaudited)
                                                                                              
Operating activities:
       Net income                                                                 $  21,334         $  19,163
       Adjustments to reconcile net income to net cash
         provided by operating activities:
       Depreciation of fixed assets                                                  15,016             7,475
       Loss on disposal of property, equipment and patents                              221             1,212
       Write-off of acquired in process research & development, one
         time charge                                                                 17,400                --
       Amortization of patent rights                                                    142               107
       Amortization of goodwill                                                       2,068                --
       Amortization of other intangible assets                                          211                --
       Issuance and amortization of deferred compensation                               407            (1,462)
       Deferred income taxes                                                         19,291                --
       Purchase of marketable trading securities                                         --            (1,786)
       Sale of marketable trading securities                                             --             2,280
       Gain on sale of available for sale securities                                 (1,379)             (494)
       Changes in operating assets and liabilities:
         Accounts receivable, net                                                   (16,113)           (8,360)
         Inventories                                                                 (2,903)           (3,105)
         Prepaid expenses and other assets                                             (618)             (624)
         Accounts payable, trade                                                        693              (266)
         Accrued expenses and long-term liability                                     1,744            11,856
                                                                                  ---------         ---------
         Net cash provided by operating activities                                   57,514            25,996
                                                                                  ---------         ---------

Investing activities:
       Acquisition fees for purchase transaction                                     (1,908)               --
       Purchase of available for sale securities                                    (10,318)         (184,429)
       Proceeds from sale of available for sale securities                            5,837                --
       Purchase of property and equipment                                           (88,193)          (47,278)
       Purchase of securities held to maturity                                     (116,528)               --
       Proceeds from securities held to maturity                                    214,998                --
       Increase in other long-term assets                                           (26,694)               (3)
       Purchase of patent rights                                                       (700)             (556)
                                                                                  ---------         ---------
         Net cash used in investing activities                                      (23,506)         (232,266)
                                                                                  ---------         ---------
Financing activities:
       Net proceeds from the issuance of short-term debt                                 --               200
       Repurchase of common stock                                                   (30,668)               --
       Net proceeds from issuance of common stock                                     9,919           271,827
                                                                                  ---------         ---------
         Net cash (used in) provided by financing activities                        (20,749)          272,027
                                                                                  ---------         ---------

Net increase in cash and cash equivalents                                            13,259            65,757

Cash and cash equivalents:
       Beginning of period                                                          103,843            42,545
                                                                                  ---------         ---------
       End of period                                                              $ 117,102         $ 108,302
                                                                                  ---------         ---------
Supplemental disclosure of cash flow information:
       Cash paid for income taxes                                                 $     611         $     268

       Common stock issued in connection with purchase business
         combination                                                              $ 113,500         $      --
                                                                                  =========         =========




         The accompanying notes are an integral part of the consolidated
                             financial statements.


   6

                                   CREE, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)


BASIS OF PRESENTATION

The consolidated balance sheet as of March 25, 2001, the consolidated statements
of income for the three and nine months ended March 25, 2001 and March 26, 2000,
and the consolidated statements of cash flow for the nine months ended March 25,
2001 and March 26, 2000 have been prepared by the Company and have not been
audited. In the opinion of management, all normal and recurring adjustments
necessary to present fairly the consolidated financial position, results of
operations and cash flow at March 25, 2001, and for all periods presented have
been made. The balance sheet at June 25, 2000 has been derived from the audited
financial statements as of that date.

Certain information and footnote disclosures normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States have been condensed or omitted. It is suggested that these
condensed consolidated financial statements be read in conjunction with the
financial statements and notes thereto included in the Company's fiscal 2000
Form 10-K. The consolidated results of operations for the periods ended March
25, 2001 are not necessarily indicative of the operating results that may be
attained for the entire fiscal year.

ACCOUNTING POLICIES

Business Combination

On May 1, 2000, the Company acquired Nitres, Inc. in a business combination
accounted for as a pooling of interests. Nitres, Inc., became a wholly owned
subsidiary (Cree Lighting Company) of the Company through the exchange of
3,695,492 shares of the Company's common stock for all of the outstanding stock
of Nitres, Inc. In addition, the Company assumed outstanding stock options and
warrants, which after adjustment for the exchange represented a total of 304,446
options and warrants to purchase shares of Cree's common stock. All prior period
consolidated financial statements have been restated to include the results of
operations, financial position and cash flows of Nitres, Inc., as though Nitres,
Inc. had been a part of the Company for all periods presented.

On December 29, 2000 the Company completed the acquisition of the UltraRF
division of Spectrian Corporation, through the purchase of the assets of the
business by Cree's wholly owned subsidiary, Ultra RF, Inc. ("UltraRF") in a
business combination accounted for under the purchase method. Under the terms of
the Asset Purchase Agreement, Ultra RF acquired substantially all of the net
assets of the business from Spectrian Corporation in exchange for a total of
2,656,917 shares of Cree common stock valued at $113.5 million. Of the total
shares issued, 191,094 shares were placed in escrow to secure Spectrian's
representations, warranties and covenants under the Asset Purchase Agreement.
The escrow period is one year, with 50% of the escrowed shares to be released
after six months if there have been no indemnification claims.



   7

The consolidated financial statements reflect the allocation of the purchase
price to fair value of the assets acquired, including goodwill of $81.7 million
and other intangible assets of $6.3 million. Goodwill is being amortized on a
straight-line basis over ten years and other related intangibles are being
amortized over five to eight years. In connection with the acquisition of the
UltraRF business, the Company recognized a one-time charge of $17.4 million
representing the write-off of the appraised value of certain acquired in-process
research and development costs as of the acquisition date.

UNAUDITED PRO FORMA SUMMARY

The following unaudited pro forma summary for the nine months ended March 25,
2001 and March 26, 2000 presents the condensed consolidated results of
operations as if the acquisition of UltraRF made during 2001 had occurred as of
June 26, 2000 and June 28, 1999, respectively. These unaudited pro forma results
have been prepared for comparative purposes only and do not purport to be
indicative of what would have occurred had the acquisition been made as of June
26, 2000 or June 28, 1999 or of results that may occur in the future.



                                     Nine Months Ended                     Nine Months Ended
                                      March 25, 2001                         March 26, 2000
                                     -----------------                     -----------------
                                            (In thousands, except per share amounts)
                                                                     
Revenue                                  $149,631                                $98,897
Net income                                 18,244                                 17,541

Basic net income per share               $   0.25                                $  0.26
Diluted net income per share             $   0.24                                $  0.25



Principles of Consolidation

The consolidated financial statements include the accounts of Cree, Inc., and
its wholly-owned subsidiaries, Cree Lighting Company ("Cree Lighting"), Ultra
RF, Inc., Cree Research FSC, Inc., Cree Funding LLC, Cree Employee Services
Corporation, CI Holdings, Limited and Cree Technologies, Inc. All material
intercompany accounts and transactions have been eliminated in consolidation.

Reclassifications

Certain fiscal 2000 amounts in the accompanying consolidated financial
statements have been reclassified to conform to the 2001 presentation. These
reclassifications had no effect on previously reported net income or
shareholder's equity.

Fiscal Year

The Company's fiscal year is a 52 or 53 week period ending on the last Sunday in
the month of June. Accordingly, all quarterly reporting reflects a 13-week
period in fiscal 2001 and fiscal 2000. The Company's current fiscal year extends
from June 26, 2000 through June 24, 2001.


                                        7
   8

Cash and Cash Equivalents

Cash and cash equivalents consist of unrestricted cash accounts and highly
liquid investments with an original maturity of three months or less when
purchased.

Fair Value of Financial Instruments

The carrying amounts of cash and cash equivalents, short-term and long-term
investments, available for sale securities, accounts and interest receivable,
accounts payable and other liabilities approximate fair values at March 25, 2001
and June 25, 2000.

Investments

Investments are accounted for in accordance with Statement of Financial
Accounting Standards No. 115, (SFAS No. 115) "Accounting for Certain Investments
in Debt and Equity Securities". This statement requires certain securities to be
classified into three categories:

         (a)      Securities Held-to-Maturity -- Debt securities that the entity
                  has the positive intent and ability to hold to maturity are
                  reported at amortized cost.

         (b)      Trading Securities -- Debt and equity securities that are
                  bought and held principally for the purpose of selling in the
                  near term are reported at fair value, with unrealized gains
                  and losses included in earnings.

         (c)      Securities Available-for-Sale -- Debt and equity securities
                  not classified as either securities held-to-maturity or
                  trading securities are reported at fair value with unrealized
                  gains and losses excluded from earnings and reported as a
                  separate component of shareholders' equity.

As of March 25, 2001 and June 25, 2000, the Company's short-term investments
held to maturity included $78.0 million and $142.5 million, respectively, in
high-grade corporate bonds. The company purchased the investments with a portion
of the proceeds from its public stock offering in January 2000. The Company has
the intent and ability to hold these securities until maturity; therefore, they
are accounted for as "securities held-to maturity" under SFAS 115. The
securities are reported on the consolidated balance sheets at amortized cost, as
a short-term investment with unpaid interest included in interest receivable.

As of March 25, 2001 and June 25, 2000, the Company's long-term investments
consisted of $8.0 million and $42.0 million, respectively, in high-grade
commercial paper. The Company purchased the commercial paper with a portion of
the proceeds from the public stock offering in January 2000. The Company has the
intent and ability to hold these securities until maturity; therefore, they are
accounted for as "securities held-to-maturity" under SFAS 115. The securities
are reported on the balance sheet at amortized cost, as long-term marketable
securities with unpaid interest included in accounts receivable if interest is
due in less than 12 months, and as a long term receivable if interest is due in
more that 12 months.

At March 25, 2001 and June 25, 2000, the Company held a short-term equity
investment in common stock of Microvision, Inc. ("MVIS"). The Company purchased
268,600 common


                                        8
   9

shares in a private equity transaction in May 1999 at a price of $16.75 per
share, or $4.5 million. Pursuant to an agreement signed March 17, 2000, the
Company committed to increase its equity position in MVIS by investing an
additional $12.5 million in MVIS common stock. This additional investment was
completed on April 13, 2000, when the Company purchased 250,000 shares at a
price of $50.00 per share. In June 2000, 162,600 MVIS shares were sold for $6.3
million, with a gain for $3.6 million realized from the sale. The Company has
also purchased other securities for investment purposes. Management views these
transactions as investments, and the shares are accounted for as "available for
sale" securities under SFAS 115. Therefore unrealized gains or losses are
excluded from earnings and are recorded in other comprehensive income or loss,
net of tax.

During the three and nine months ended March 25, 2001, the Company realized
gains of $199,000 and $1.4 million, respectively, from the sale of
available-for-sale securities. During the three and nine months ended March 26,
2000, the Company realized gains of $494,000 and $494,000, respectively, from
the sale of available-for-sale securities. For the three and nine months ended
March 25, 2001, the Company had unrealized holding losses of $1.5 million and
$12.1 million, respectively, associated with investments made in available for
sale securities.

Inventories

Inventories are stated at the lower of cost or market, with cost determined
under the first-in, first-out (FIFO) method. Inventories consist of the
following:



                                            March 25,         June 25,
                                              2001              2000
                                            ---------        ---------
                                                  (In thousands)
                                                       
          Raw materials                     $   4,156        $   2,415
          Work-in-progress                      6,568            3,094
          Finished goods                        5,129            3,811
                                            ---------        ---------
          Total Inventory                   $  15,853        $   9,320
                                            =========        =========


Research and Development Agreements

The U.S. Government provides funding through research contracts for several of
the Company's current research and development ("R&D") efforts. The contract
funding may be based on either a cost-plus or a cost-share arrangement. The
amount of funding under each contract is determined based on cost estimates that
include direct costs, plus an allocation for research and development, general
and administrative and the cost of capital expenses. Cost-plus funding is
determined based on actual costs plus a set percentage margin. For the
cost-share contracts, the actual costs are divided between the U.S. government
and the Company based on the terms of the contract. The government's cost share
is then paid to the Company. Activities performed under these arrangements
include research regarding silicon carbide and gallium nitride materials. The
contracts typically require the submission of a written report that documents
the results of such research.

The revenue and expense classification for contract activities is based on the
nature of the contract. For contracts where the Company anticipates that funding
will exceed direct costs over the life of the contract, funding is reported as


                                       9
   10

contract revenue and all direct costs are reported as costs of contract revenue.
For contracts under which the Company anticipates that direct costs will exceed
amounts to be funded over the life of the contract, costs are reported as
research and development expenses and related funding as an offset of those
expenses. The following table details information about contracts for which
direct expenses exceed funding by period included in research and development
expenses:



                                       Three Months Ended                 Nine Months Ended
                                   --------------------------        --------------------------
                                   March 25,        March 26,        March 25,        March 26,
                                     2001             2000             2001             2000
                                   ---------        ---------        ---------        ---------
                                                         (In thousands)
                                                                          
Net R&D costs                      $     160        $     164        $     399        $     298
Government funding                       371              227            1,031              625
                                   ---------        ---------        ---------        ---------
Total direct costs incurred        $     531        $     391        $   1,430        $     923
                                   =========        =========        =========        =========


Significant Sales Contracts

In July 2000, the Company entered into a new Purchase Agreement with Osram Opto
Semiconductors GmbH & Co. ("Osram"), pursuant to which Osram agreed to purchase
and the Company is obligated to ship certain quantities of standard-brightness,
high-brightness and ultra-bright LED chips and silicon carbide wafers through
September 2001.

The Osram agreement calls for certain quantities of standard-brightness,
high-brightness and ultra-bright LED chips to be delivered by month. In the
event the Company is unable to ship at least 85% of the cumulative quantity due
to have been shipped each month, Osram is entitled to liquidated damages. These
damages are calculated at one percent per week of the purchase price of the
delayed product, subject to a maximum of ten percent of the purchase price. If
product shipments are delayed six weeks or more due to circumstances within the
Company's control, then in lieu of liquidated damages, Osram may claim damages
actually resulting from the delay up to 40% of the purchase price of delayed
products.

The contract also gives Osram limited rights to defer shipments. For products to
be shipped in more than 24 weeks after initial notice, Osram can defer 30% of
standard-brightness LED's and 25% of high-brightness and ultra-bright LEDs,
respectively. For products to be shipped in more than 12 weeks, but less than 24
weeks, Osram may defer 10% of scheduled quantities for standard-brightness,
high-brightness and ultra-bright LEDs. In each case, Osram is required to accept
all products within 90 days of the original shipment date. In all other cases,
Osram may reschedule shipments only with the Company's mutual written agreement.

Additionally, the Purchase Agreement provides for higher per unit prices early
in the contract with reductions in unit prices being available as the cumulative
volume shipped increases. The higher prices were negotiated by the Company to
offset higher per unit costs expected earlier in the contract.

In December 2000, the Company's subsidiary, UltraRF, entered into a Supply
Agreement with Spectrian. Under this agreement, Spectrian has committed to
purchase semiconductor components having a minimum aggregate purchase price of
approximately $58.0 million during


                                       10
   11

the two years ended December 31, 2002. In addition, UltraRF agreed to allocate
sufficient capacity to supply Spectrian with quantities in excess of its minimum
commitment by up to 20%. The minimum purchase amounts are fixed for each quarter
during the two-year term of the agreement, with the aggregate of the eight
quarters equaling $58.0 million. Cree, UltraRF and Spectrian also entered into a
development agreement, under which Spectrian has agreed to provide funding of
$2.4 million during calendar 2001. This work will support development by Cree
and UltraRF directed to improve high linearity and gain laterally diffused metal
oxide semiconductors ("LDMOS") power modules, and silicon carbide based RF power
transistors for potential use in Spectrian's power amplifier products.

Income Taxes

The Company has established an estimated tax provision based upon an effective
rate of 34%. The estimated effective rate was based upon projections of income
for the fiscal year and the Company's ability to utilize remaining net operating
loss carryforwards and other tax credits. However, the actual effective rate may
vary depending upon actual pre-tax book income for the year or other factors.

Shareholders' Equity

On January 18, 2001, the Company announced that its Board of Directors has
authorized the repurchase of up to four million shares, or about five percent,
of its outstanding common stock. Additionally, on March 22, 2001, the Company
announced that its Board of Directors increased the repurchase limits under the
stock repurchase program announced in January 2001 to include an additional
three million shares, for a total of seven million shares of its outstanding
common stock. As of March 25, 2001, the Company repurchased 1.85 million shares
of its common stock at an average price of $16.58 per share.

The Company expects to use available cash to finance purchases under the
program, which extends to January 2002. At the discretion of the Company's
management, the repurchase program can be implemented through open market or
privately negotiated transactions. The Company will determine the time and
extent of repurchases based on its evaluation of market conditions and other
factors.

In connection with the stock repurchase program, and in addition to the
purchases described above, the Company sold put options covering an aggregate of
1.95 million shares for an aggregate premium of $2.9 million in January 2001.
The options are exercisable on a specific date in the fourth quarter of fiscal
2001, at an average exercise price of $19.52 per share. The put options were
sold to investment banks without registration in reliance on the exemption
provided by Section 4 (2) of the Securities Act of 1933, as amended. Each
transaction was privately negotiated with the purchaser, which was an accredited
investor.

(LOSS) EARNINGS PER SHARE

The Company presents (loss) earnings per share in accordance with Statement of
Financial Accounting Standards No. 128, "Earnings Per Share" ("SFAS 128").


                                       11
   12

The following computation reconciles the differences between the basic and
diluted presentations:




                                                          Three Months Ended                 Nine Months Ended
                                                     --------------------------        --------------------------
                                                     March 25,        March 26,        March 25,        March 26,
                                                       2001            2000(*)           2001            2000(*)
                                                     ---------        ---------        ---------        ---------
                                                                (In thousands except per share amounts)
                                                                                            
Net (loss) income                                    $  (5,182)        $   8,962        $  21,334        $  19,163
Weighted average common shares                          73,920            68,031           72,075           64,424
                                                     ---------         ---------        ---------        ---------
Basic (loss) earnings per common share               $   (0.07)        $    0.13        $    0.30        $    0.30
                                                     =========         =========        =========        =========

Net (loss) income                                    $  (5,182)        $   8,962        $  21,334        $  19,163
Diluted weighted average common shares:
Common shares outstanding                               73,920            68,031           72,075           64,424
Dilutive effect of stock options and warrants               --             5,091            3,743            4,420
                                                     ---------         ---------        ---------        ---------
Total diluted weighted average common shares            73,920            73,122           75,818           68,844
                                                     ---------         ---------        ---------        ---------
Diluted (loss) earnings per common share             $   (0.07)        $    0.12        $    0.28        $    0.28
                                                     =========         =========        =========        =========


(*) Weighted average shares and per share amounts have been adjusted for the two
for one stock split effective December 1, 2000.

In accordance with SFAS 128, 5,951,074 shares for the three and nine months
ended March 25, 2001, respectively, were not included in calculating diluted
(loss) income per share for the periods presented. For the three and nine months
ended March 26, 2000, there were no potential shares considered antidilutive.

The Company effected a two-for-one split of its common stock in December 2000.
The stock split was effected by an amendment to the Company's Articles of
Incorporation that became effective at the close of business on December 1,
2000. Each issued and unissued authorized share of common stock, $0.0025 par
value per share, was automatically split into two whole shares of common stock,
$0.00125 par value per share. On December 8, 2000, the Company issued to each
holder of record of common stock a certificate evidencing the additional shares
of common stock resulting from the stock split. All references in this document
to common stock and per common share data have been adjusted to reflect the
common stock split, unless otherwise stated.

BUSINESS SEGMENTS

The Company operates in two business segments, Cree and UltraRF. The Cree
segment incorporates its proprietary technology to produce LEDs, silicon carbide
wafers and government contract research. Products from this segment are used in
automotive and liquid crystal display backlighting; indicator lamps, full color
light emitting diode displays and other lighting applications as well as power
applications and research.


                                       12
   13

The UltraRF segment designs, manufactures and markets a complete line of silicon
based LDMOS and bipolar radio frequency power semiconductors, the critical
component utilized in building power amplifiers for wireless infrastructure
applications.

Summarized financial information concerning the reportable segments for the
three and nine months ended March 25, 2001 are shown in the following table. The
"Other" column represents amounts excluded from specific segments such as
interest income. In addition, the "Other" column also includes corporate assets
such as cash and cash equivalents, short-term investments held to maturity,
marketable securities, interest receivable and long-term investments held to
maturity which have not been allocated to a specific segment.



                                                        Cree             UltraRF           Other            Total
                                                      --------          --------          --------         --------
                                                                              (In thousands)
                                                                                               
Three Months Ended March 25, 2001
Revenue                                               $ 44,064          $  9,301          $      0         $ 53,365
Income (loss) before income taxes                       14,735           (17,446)            3,824            1,113
Assets                                                $293,807          $102,746          $214,962         $611,515





                                                        Cree            UltraRF            Other            Total
                                                      --------          --------          --------         --------
                                                                              (In thousands)
                                                                                               
Nine Months Ended March 25, 2001
Revenue                                               $123,200          $  9,301          $      0         $132,501
Income (loss) before income taxes                       45,851           (17,446)           12,929           41,334
Assets                                                $293,807          $102,746          $214,962         $611,515




                                       13
   14

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

Information set forth in this Form 10-Q, including Management's Discussion and
Analysis of Financial Condition and Results of Operations, contains various
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Act of 1934. These statements
represent our judgment concerning the future and are subject to risks and
uncertainties that could cause our actual operating results and financial
position to differ materially. Such forward-looking statements can be identified
by the use of forward-looking terminology such as "may," "will," "anticipate,"
"believe," "plan," "estimate," "expect," and "intend" or the negative thereof or
other variations thereof or comparable terminology. We caution that such
forward-looking statements are further qualified by important factors that could
cause our actual operating results to differ materially from those
forward-looking statements. These factors include, but are not limited to,
uncertainties regarding economic condition; risks from increased competition;
uncertainty whether we can achieve our targets for increased yields and cost
reductions needed to permit lower product pricing without margin reductions;
risks associated with the production ramp-up for our ultra-bright LED chips,
including the possibility of unexpected delays, increased costs and
manufacturing difficulties or less than expected market acceptance; risks
associated with the planned release of new products under development, including
the possibility we will be unable to develop and manufacture commercially viable
versions of such products; the risk of variability in our manufacturing
processes that can adversely affect yields and product performance; uncertain
product demand; concentration of our business among few customers; whether we
can manage our growth and integrate acquired businesses effectively; uncertainty
whether our intellectual property rights will provide meaningful protection; the
possibility of adverse results in our pending intellectual property litigation
and general economic conditions. See Exhibit 99.1 for further discussion of
factors that could cause our actual results to differ.

Overview

Cree, Inc. is the world leader in developing and manufacturing semiconductor
materials and electronic devices made from silicon carbide ("SiC") and gallium
nitride ("GaN"). We recognize product revenue at the time of shipment or in
accordance with the terms of the relevant contract. We derive the largest
portion of our revenue from the sale of blue and green light emitting diode
("LED") products. We offer LEDs at three brightness levels: ultra-bright blue
and green devices, high-brightness blue and green products and
standard-brightness blue products. Our LED devices are utilized by end users for
automotive dashboard lighting, liquid crystal display ("LCD") backlighting,
including wireless handsets and other consumer products, indicator lamps,
miniature white lights, indoor sign and arena displays, outdoor full color
displays, traffic signals and other lighting applications.

We introduced our new ultra-bright LED products in the second quarter of fiscal
2001. We believe the ultra-bright products are two-times brighter than our
high-brightness devices, and they will replace some of the demand for our older
products over time. The ultra-bright chips are priced slightly higher than the
high-brightness devices; therefore, the cost per lumen of brightness to the
customer has been substantially reduced with the introduction of this product.
As a result, during the third quarter of fiscal 2001, revenues derived from
ultra-bright LED


                                       14
   15

products increased from 8% of our total LED revenue in the second quarter of
fiscal 2001 to 39% of revenue in the third quarter of fiscal 2001.

During the third quarter of fiscal 2001, our high-brightness chips comprised the
largest portion of our revenue at 42% of LED sales. However, these sales have
declined as a percentage of total LED revenue from 79% in the quarter ended
December 2000 due to the sales of our new ultra-bright products. Revenues from
the standard-brightness products were fairly flat as a percentage of our LED
sales mix during the third quarter of fiscal 2001. Over the next few quarters,
LED revenue mix by product is targeted to remain near the same range as the
March 2001 quarter.

We anticipate that new designs targeted to be ready for sale in the first half
of fiscal 2002 will create a greater demand for our ultra-bright devices. In
addition, we announced a new LED product design, our megabright chip, that we
target to be released in volume production in June 2001. We believe this product
offers two-times the brightness of our ultra-bright devices and will likely
benefit customers who provide outdoor displays, automotive designs, PDA's and
solid state illumination products. In addition, we are in the later stages of
developing a new ultra violet ("UV") LED product that we are targeting to be
available beginning in the first half of fiscal 2002 in limited quantities for
white light conversion applications.

Through the first nine-months of fiscal 2001, average sales prices for LEDs have
declined 20%. We target average sales prices for these products to decline at a
rate of 25% to 30% for the entire fiscal year.

We derive additional revenue from the sale of advanced materials made from SiC
that are used primarily for research and development for new semiconductor
applications. During the third quarter of fiscal 2001, sales of SiC wafers
increased by 120% over the third quarter of fiscal 2000. Strong demand from the
corporate and research communities is driving this growth, including new
interest in SiC for microwave and power devices from certain customers. During
the quarter, we continued process refinement to lower costs of two-inch product
while improving quality and manufacturing processes for three-inch material. We
continue to expand our epitaxial capabilities for three-inch production of
nitride and SiC based products. For some RF and power products it is critical
that we get these processes on line so that we can deliver devices at the proper
price point and margins. There was no revenue from gemstone sales during the
third quarter of fiscal 2001.

During the quarter ended March 25, 2001, UltraRF exceeded our revenue
expectation at $9.3 million. In the long term, UltraRF's success will depend on
the rate at which we diversify our Spectrian-concentrated business. However, we
experienced a strong quarter from Spectrian, with sales extending beyond the
minimum purchase requirements in our contract. We believe the LDMOS product line
will enable growth of our products to customers other than Spectrian. These
products focus on multi-carrier applications and may allow for new design wins.

The balance of our revenue is derived from government and customer research
contract funding.

We continue to focus on cost reduction as one of our highest priorities. During
the past twelve months, we maximized our capacity and have invested in
additional plant and equipment and other infrastructure that has increased our
overall cost base. We anticipate that we will use much of this equipment and
infrastructure in the near term to perform research and development work


                                       15
   16

to support the commercialization and growth of future products. We are also now
thoroughly examining our cost structure and identifying ways to minimize costs
through vendor negotiations, process improvements and other efficiencies and to
increase overall yields. We believe that a successful cost reduction program
will be critical to meeting our profit objectives over the next several
quarters.


RESULTS OF OPERATIONS

Three Months Ended March 25, 2001 and March 26, 2000

Revenue. Revenue grew 81% from $29.5 million in the third quarter of fiscal 2000
to $53.4 million in the third quarter of fiscal 2001. This increase was
attributable to a rise in product revenue of 84% from $26.2 million in the third
quarter of fiscal 2000 to $48.0 million in the third quarter of fiscal 2001.
Without the acquisition of Ultra RF, revenue for the third quarter would have
increased 49% over the prior year comparative results. Much of the increase in
revenue for our core business unit resulted from demand for our LED and silicon
carbide wafer products. LED chip volume increased 127% over units delivered in
the third quarter of last year. Our new ultra-bright LED products showed the
highest percentage gain over the December 2000 quarter as unit shipments
increased more than five times. Ultra bright products, which are approximately
two times brighter than our high-brightness chips, made up more than 24% of our
total chip volume and 39% of total LED revenue during the quarter. The ultra
bright products will likely continue to replace some of the demand for older
devices, as new customer product qualifications are completed. As a result of
the growth of these products, our high-brightness chips declined sequentially
from 71% in the December 2000 quarter to 42% of LED sales for the March 2001
quarter. Sales of our standard-brightness chips continued to be strong in the
third quarter of fiscal 2001 as volume increased 153% over the same quarter in
the prior year due to the timing of demand for automotive applications, displays
and indicator lights. Average LED sales prices declined 27% in the third quarter
of fiscal 2001 compared to the third quarter of fiscal 2000, and 6%
sequentially, due to expected contractual volume discounts given to customers.

SiC wafer sales increased 120% in the third quarter of fiscal 2001 compared to
the same period of fiscal 2000. This is due to demand from the corporate and
research communities, including new interest in SiC for microwave and power
devices from certain customers and other customers now using our SIC wafers for
commercial production. Wafer units have increased 148%, while average sales
prices have declined 11% in the third quarter of fiscal 2001 compared to the
third quarter of fiscal 2000. Sales of gemstone products declined 100% during
the third quarter of fiscal 2001 compared to the third quarter of fiscal 2000,
as there were no sales to Charles & Colvard ("C&C") during the March 2001
quarter. We anticipate little to no revenue from this customer over the next
several quarters.

Revenue from our newly acquired UltraRF subsidiary was $9.3 million during the
March 2001 quarter, which was relatively unchanged from results reported by
UltraRF as a division of Spectrian Corporation in the December 2000 quarter.
UltraRF continues to ramp its production of LDMOS products currently being
shipped for next generation wireless base station applications while working on
new customer design wins. We acquired Ultra RF in December 2000; therefore,
there were no sales for this unit in the comparable March 2000 quarter.


                                       16
   17

Contract revenue received from U.S. Government agencies and non-governmental
customers increased 59% during the third quarter of fiscal 2001 compared to the
third quarter of fiscal 2000 due to additional contract awards received. During
the past 12 months, our Cree Lighting subsidiary, and we were awarded 12 new
government funded contracts. In addition, certain prior year rate adjustments
were recorded which increased revenue in the March 2001 quarter.

Gross Profit. Gross profit increased 63% to $25.7 million in the third quarter
of fiscal 2001 compared to $15.8 million in the third quarter of fiscal 2000.
Compared to the prior year, gross margin decreased to 48% from 54% of revenue.
Lower margins resulted from the combination of the UltraRF business, where gross
margins were 42% of revenue for the third quarter of fiscal 2001. Margins were
lower for this unit due to one-time adjustments to record costs associated with
acquired inventory at fair value in accordance with the purchase method of
accounting, in addition to other adjustments to costs. Without these
adjustments, margins at UltraRF would have been 49%. Our product margin,
excluding UltraRF, would have been 53% of revenue for the March 2001 quarter.
The LED line also realized lower profitability due to contractual declines in
average sales prices combined with flat costs. In the March 2001 quarter, we
made chip modifications to certain LED products that we believe will improve our
competitive advantage for new design wins. We believe the challenges involved
with learning this new process were mostly overcome during the third quarter of
fiscal 2001, therefore, we target improved yields for our LED products in the
fourth quarter of 2001. Wafer costs for SIC material sales were also flat in the
third quarter of fiscal 2001, compared to results in the third quarter of fiscal
2000.

Research and Development. Research and development expenses increased 64% or
$1.4 million in the third quarter of fiscal 2001 to $3.6 million from $2.2
million in the third quarter of fiscal 2000. Increased spending for research and
development results from the combination of UltraRF expenses and increased
internal funding to support microwave and optoelectronic programs. Without the
addition of UltraRF expenses, research and development costs would have
increased 32% from the third quarter of fiscal 2000. Internal funding for
programs is targeted to accelerate in the next several months as we increase our
efforts to develop new products that we believe will improve our competitive
position and create new opportunities for the use of silicon carbide and gallium
nitiride in the marketplace.

Sales, General and Administrative. Sales, general and administrative expenses
increased 76% or $2.2 million in the third quarter of fiscal 2001 to $5.1
million from $3.0 million in the third quarter of fiscal 2000, due to the
combination of UltraRF expenses and significant legal costs primarily associated
with patent litigation. Excluding UltraRF results, selling, general and
administrative expenses would have been 37% higher, which is directly attributed
to costs incurred during the March 2001 quarter in connection with ongoing
intellectual property litigation.

Intangible Assets Amortization and In-Process Research and Development Costs. As
a result of the acquisition of UltraRF, we generated goodwill and other
intangible assets, which will be amortized over periods ranging from five to 10
years. In addition, due to the combination with Ultra RF, we recorded a one-time
charge of $17.4 million in the third quarter of fiscal 2001 associated with
acquired in-process research and development costs.


                                       17
   18

Other (Income) Expense. Other expense decreased to $158,000 during the third
quarter of fiscal 2001 from $1.2 million recognized for the third quarter of
fiscal 2000. This decrease is attributable to the disposal of fewer fixed assets
during the quarter.

Other Non Operating Income (Loss). Other non-operating income declined $333,000
to $162,000 for the third quarter of fiscal 2001 due to reduced gains from the
sale of trading securities being recognized.

Interest Income, Net. Interest income, net has remained constant at $3.8 million
for the third quarter of fiscal 2001 and fiscal 2000.

Income Tax Expense. Income tax expense for the third quarter of fiscal 2001 was
$6.3 million compared to $4.7 million in the third quarter of fiscal 2000. The
increase in income tax expense resulted from higher income before income taxes,
adjusted for acquired in-process research and development charges, which were
not deductible for tax purposes during the third quarter of fiscal 2001. The
income tax provision rate was 34% for both periods.

Nine Months Ended March 25, 2001 and March 26, 2000

Revenue. Revenue increased 76% from $75.2 million in the first nine months of
fiscal 2000 to $132.5 million in the first nine months of fiscal 2001. This
increase resulted from a rise in product revenue of 80% from $66.6 million in
the first nine months of fiscal 2000 to $119.9 million in the first nine months
of fiscal 2001. Greater product revenue was largely a result of the 100%
increase in sales of our LED products in the first nine months of fiscal 2001
compared to the first nine months of fiscal 2000. Our high-brightness LED
products experienced the heaviest demand; however, units sold of our
standard-brightness chips also increased 38% during the comparative period.
Overall LED chip volume grew 135% in the first nine months of fiscal 2001 over
units shipped in the first nine months of fiscal 2000, while our average sales
prices for LEDs sold during each period declined 15% due to expected contractual
volume discounts.

SiC wafer sales increased 72% in the first nine months of fiscal 2001 compared
to the same period of fiscal 2000, due to heavy demand from the corporate and
research communities, including new interest in SiC for microwave and power
devices from certain customers. Wafer units have increased 122%, while average
sales prices have declined 15% in the first nine months of fiscal 2001 compared
to the first nine months of fiscal 2000. Average sales prices declined due to a
shift in mix to high volume products now used by our customers in their
commercial production applications.

Revenue attributable to sales of SiC material used in the gemstone business was
58% lower in the first nine months of fiscal 2001 than in the same period of
fiscal 2000. This decline was due to C&C ramping up their gemstone business in
the first half of fiscal 2000, while reducing their orders in fiscal 2001 as
they balance their inventory. We anticipate little to no revenue from the
gemstone business over the next several quarters.

Revenue from UltraRF increased 100% during the first nine months of fiscal 2001
compared to the same period in fiscal 2000, as we acquired the UltraRF business
in a purchase transaction on December 29, 2000.


                                       18
   19

Contract revenue received from U.S. Government agencies and customers increased
45% during the first nine months of fiscal 2001 compared to the first nine
months of fiscal 2000. Contract revenue grew over the same period of the prior
year due to new contract awards, increases in funding under existing programs
and rate adjustments recorded. During the 12 months ended March 2001, our Cree
Lighting Company subsidiary and we were awarded 12 new government funded
contracts.

Gross Profit. Gross profit increased 80% from $38.0 million in the first nine
months of fiscal 2000 to $68.3 million in the first nine months of fiscal 2001.
This increase is due primarily to the rise in LED sales. Margin on LED products
also improved in the nine months ending March 2001 as compared to the same
period in the prior year as average LED sales prices were reduced 15% while
average LED costs were 16% lower due to higher throughput and manufacturing
yield on high-brightness LEDs. Margins on wafer products declined during the
first nine months of fiscal 2001 compared to the same period in the prior year
as average sales prices decreased 15% while costs were reduced 12%.

Research and Development. Research and development expenses increased 57% in the
first nine months of fiscal 2001 to $8.0 million from $5.1 million in the first
nine months of fiscal 2000. Much of this increase resulted from the acquisition
of UltraRF, as well as a greater investment made for research in the RF and
microwave, power and optoelectronics programs. We believe that internal funding
for the development of new products will continue to grow especially in the next
few quarters.

Sales, General and Administrative. Sales, general and administrative expenses
increased 55% in the first nine months of fiscal 2001, to $12.1 million, from
$7.8 million in the first nine months of fiscal 2000. This increase in expenses
is due to the acquisition of Ultra RF and greater spending to support the
overall growth of the business, as well as costs associated with ongoing
intellectual property litigation.

Intangible Asset Amortization and In-Process Research and Development Costs. The
purchase of UltraRF generated goodwill and other intangible assets, which will
be amortized over periods ranging from five to 10 years. In addition, as a
result of the acquisition of UltraRF, we recorded a one-time charge of $17.4
million in the third quarter of 2001 associated with acquired in-process
research and development costs

Other (Income) Expense. Other expense decreased to $220,000 during the first
nine months of fiscal 2001 from $1.3 million for the first nine months of fiscal
2000. The decrease was attributable to fewer fixed asset disposals.

Other Non Operating Income (Loss). Other non-operating income declined $432,000
to $ 63,000 for the first nine months of fiscal 2001 due to reduced gains from
the sale of trading securities being recognized.

Interest Income, Net. Interest income, net increased 163% to $12.9 million in
the first nine months of fiscal 2001 from $4.9 million in the first nine months
of fiscal 2000. This was due to higher average cash balances being available in
the first nine months of fiscal 2001 as a result of the public stock offering
completed in January 2000. Higher interest rates in the first nine months of
fiscal 2001 also improved interest income.


                                       19
   20

Income Tax Expense. Income tax expense for the first nine months of fiscal 2001
was $20.0 million compared to $10.1 million in the first nine months of fiscal
2000. This increase resulted from higher profitability during the first nine
months of fiscal 2001 over the same period in fiscal 2000, as adjusted for the
cost of in-process research and development which is non-deductible in the
current period. Our income tax provision rate was 34% for both periods.

LIQUIDITY AND CAPITAL RESOURCES

We have funded our operations to date through sales of equity, bank borrowings
and revenue from product and contract sales. As of March 25, 2001, we had
working capital of $215.2 million, including $204.7 million in cash and
short-term investments. Operating activities generated cash of $57.5 million for
the first nine months of fiscal 2001 compared with $26.0 million generated
during the comparative period in fiscal 2000. This increase was primarily
attributable to higher profitability.

Most of the $23.5 million used in investing activities in the first nine months
of fiscal 2001 was related to the purchase of securities held to maturity of
$116.5 million. In addition, we spent $88.1 million in capital expenditures
during the first nine months of fiscal 2001 compared to $47.0 million during the
same period in the prior fiscal year. The majority of the increase in spending
was due to new equipment additions to increase manufacturing capacity in our
epitaxy, cleanroom and package and test areas. We are also nearing the
completion of a 125,000 square foot facility expansion at our production site
near Research Triangle Park, North Carolina. The increase in other long-term
assets of $26.7 million in the first nine months of fiscal 2001 represents
strategic investments made in private companies. Proceeds of $215.0 million from
the sale of securities held to maturity were used to fund these investing
activities.

Cash used in the financing activities included a common stock repurchase of
1,850,000 shares on the open market for $30.7 million. In addition, we received
$9.9 million in proceeds from the exercise of stock options from our employee
stock option plan and the exercise of outstanding stock warrants.

We may issue additional shares of common stock for the acquisition of
complementary businesses or other significant assets. From time to time we
evaluate potential acquisitions of and investments in complementary businesses
and anticipate continuing to make such evaluations.


ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE DISCLOSURES

As of March 25, 2001, the Company maintains investments in equity securities
that are treated for accounting purposes under SFAS 115 as ""available for sale"
securities. These investments are carried at fair market value based on quoted
market prices of the investments as of March 25, 2001, with net unrealized gains
or losses excluded from earnings and reported as a separate component of
stockholder's equity. These investments are subject to market risk of equity
price changes. Management views these stock holdings as investments; therefore,
the shares are


                                       20
   21

accounted for as "available for sale" securities under SFAS 115. The fair market
value of these investments as of March 25, 2001, using the closing sale price of
March 23, 2001, was $9.6 million.

During the first nine months of fiscal 2001, the Company invested some of the
proceeds from its January 2000 public offering in other investments at fixed
interest rates that vary by security. No other material changes in market risk
were identified during the most recent quarter.


QUALITATIVE DISCLOSURES

Investments in the common stock of other public companies are subject to the
market risk of equity price changes. While the Company can not predict or manage
the future market price for such stock, management continues to evaluate its
investment position on an ongoing basis.

PART II - OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS

As discussed in the Company's reports on Form 10Q filed November 3, 2000 and
February 2, 2001, the Company and North Carolina State University ("NCSU")
commenced a patent infringement lawsuit on September 22, 2000 against Nichia
Corporation and Nichia America Corporation in the United States District Court
for the Eastern District of North Carolina. In their answer to the complaint,
Nichia Corporation and Nichia America Corporation denied infringement and
asserted counterclaims seeking a declaratory judgement that the subject patent
is invalid, and non infringed. Nichia America Corporation also moved on December
11, 2000, for partial summary judgement seeking a determination that the subject
patent is invalid. The Company and NCSU have opposed the motion, which remains
pending.

Nichia Corporation also asserted counterclaims alleging that the Company is
infringing four U.S. patents relating to nitride semiconductor technology and
further asserting misappropriation of trade secrets and related claims against
the Company and a former Nichia Corporation researcher now employed by a Company
subsidiary, Cree Lighting Company, on a part-time basis. On February 20, 2001,
the Company and its counterclaim codefendant moved to dismiss the non-patent
counterclaims on the grounds that Nichia Corporation failed to allege a basis
for subject matter jurisdiction and failed to state a claim upon which relief
may be granted. The motion also seeks dismissal of certain counterclaims on
forum non-conveniens grounds.

On February 20, 2001, the Company also replied to the patent infringement
counterclaims, denying any infringement and asserting a claim seeking a
declaratory judgement that the four patents at issue are invalid, unenforceable
and not infringed. The Company also added a claim for damages in which it
alleges that Nichia Corporation's actions in asserting the patent infringement
counterclaims were not made for any legitimate purpose and constitute unfair
competition in violation of North Carolina law. On April 2, 2001, Nichia
Corporation moved to leave to file an amended answer and counterclaim that seeks
to address jurisdictional concerns, to add Cree Lighting Company as a
counterclaim defendant and to add federal statutory claims under the Computer
Fraud and Abuse Act against the Cree Lighting Company employee previously added
as a party. The motion for leave to file the amended answer and counterclaim has
been opposed and remains pending.


                                       21
   22

Motions of the parties for protective orders have been denied so discovery is
proceeding, except that the court has stayed discovery as to damages and willful
infringement issues pending ruling on a motion filed by the Company and NCSU
seeking to have the proceedings bifurcated into separate liability and damages
phases.

Although there can be no assurances of success, the Company believes the
counterclaims asserted in the North Carolina case are without merit and intends
to defend against them vigorously.

As discussed in the Company's Annual Report on Form 10-K for the fiscal year
ended June 25, 2000, the Company has also intervened in three patent
infringement lawsuits filed in Tokyo District Court by Nichia Corporation
against one of the Company's distributors. The complaint in one of these cases,
filed in December 1999, alleges that the Company's standard brightness LED
products infringe a Japanese patent owned by Nichia Corporation. The court has
closed proceedings in the case and is scheduled to render its decision during
the fourth quarter of fiscal 2001. Although there can be no assurances of
success, the Company's management believes the claims asserted in the Japanese
lawsuits are without merit and intends to defend the Company's products against
them vigorously.

ITEM 2.  CHANGES IN SECURITIES

In January 2001, the Company sold put options covering an aggregate of 1.95
million shares of its common stock. The sale of the put options is described in
the Notes to Consolidated Financial Statements (unaudited) included in Part I,
Item I of this report and such description is incorporated by reference into
this Part II, Item 2.

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

     (a)      Exhibits

     (b)
              99.1     Certain Business Risks and Uncertainties

     (b)      Reports on Form 8-K:

                  On March 19, 2001 the Company amended its Form 8-K dated
December 29, 2000 to report financial results associated with the acquisition of
Ultra RF, Inc.



                                       22
   23

                                  SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.



                                      CREE, INC.


Date: May 9, 2001               /s/ Cynthia B. Merrell
                                ----------------------------------------------
                                    Cynthia B. Merrell
                                    Chief Financial Officer and Treasurer
                                    (Authorized Officer and Chief Financial and
                                    Accounting Officer)




                                       23